Heparin, a sulfated glycosamynoglycan, being the closest mimic of HS, has been initially considered as a putative heparanase-1 inhibitor, but its strong anticoagulant activity limits its use as an anti-cancer treatment [59]. Here, HPSE is linked to cancer.